Bolt Biotherapeutics, Inc. (BOLT) PT Lowered to $6 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Daina Graybosch lowered the price target on Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) to $6.00 (from $20.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
